Healthcare Professionals
Our Products
Investor Information
LSE:BGC
- 27 Jan 2012
- closed
Quote 323.70p
Change -0.30
Information for investors and analysts.
What's New?
- BTG plc: Interim Management Statement
- BTG plc: Voraxaze® (glucarpidase) receives US regulatory approval
- Click here to access the webcast of BTG's presentation at the J.P. Morgan conference
- Interim Report and Accounts 2011
- BTG plc: Interim Results
- Check out new Career Opportunities at BTG
- IMPORTANT: Share Scam Alert for Shareholders

